The US Food and Drug Administration (FDA) has approved the first adaptive deep brain stimulation (aDBS) system for Parkinson’s disease (PD) that self-adjusts therapy to individual brain activity in ...
New closed-loop system self-adjusts DBS therapy to individual brain activity in real time; the largest commercial launch of brain-computer interface technology ever There is no cure for debilitating ...
Newronika has completed a €13.6m ($14.1m) Series B funding to advance the development of AlphaDBS, an adaptive deep brain stimulation (DBS) system for addressing the symptoms of Parkinson's disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results